NASHVILLE, Tenn. --(BUSINESS WIRE)--Sep. 26, 2023-- Melt Pharmaceuticals, Inc. , a clinical-stage pharmaceutical company developing novel approaches for procedural sedation, today announced it recently entered into an exclusive development and license agreement with Catalent, the global leader in